1. A peptide inhibitor of antibody-dependent cell-mediated cytotoxicity against EGFR/folate receptor-α double positive cells. Issue 5 (8th March 2018) Authors: Sasaki, Koichi; Miyashita, Yoshiki; Asai, Daisuke; Funamoto, Daiki; Sato, Kazuki; Yamaguchi, Yoko; Mishima, Yuji; Iino, Tadafumi; Takaishi, Shigeo; Nagano, Jun; Kishimura, Akihiro; Mori, Takeshi; Katayama, Yoshiki Journal: MedChemComm Issue: Volume 9:Issue 5(2018) Page Start: 783 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Design of a ligand for cancer imaging with long blood circulation and an enhanced accumulation ability in tumors12. Issue 6 (26th April 2017) Authors: Nakhaei, Elnaz; Kim, Chan Woo; Funamoto, Daiki; Sato, Hikari; Nakamura, Yuta; Kishimura, Akihiro; Mori, Takeshi; Katayama, Yoshiki Journal: MedChemComm Issue: Volume 8:Issue 6(2017) Page Start: 1190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia–reperfusion injury by inhibiting monocyte-mediated inflammation in mice. Issue 7 (9th March 2019) Authors: Fujiwara, Masaki; Matoba, Tetsuya; Koga, Jun-Ichiro; Okahara, Arihide; Funamoto, Daiki; Nakano, Kaku; Tsutsui, Hiroyuki; Egashira, Kensuke Journal: Cardiovascular research Issue: Volume 115:Issue 7(2019) Page Start: 1244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗